MacroGenics
MGNX
75 hedge funds and large institutions have $397M invested in MacroGenics in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 3 closing their positions.
767% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 3
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
42% more funds holding
Funds holding: 53 → 75 (+22)
38% more capital invested
Capital invested by funds: $287M → $397M (+$110M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
Top Sellers
MGNX Hedge Fund Activity: Q1 2014 in Review
75 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2014, worth a combined $397M — up 38% from $287M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MGNX positions and 3 closed out — a net gain of 23 holders — while 26 added to existing stakes and 14 trimmed.
The largest buyer was Caisse de Depot et Placement du Quebec (CDPQ), opening a new position worth an estimated $39.3M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $11.9M.
- 75 institutional investors held MacroGenics (MGNX) as of Q1 2014, up from 53 in Q4 2013.
- Funds reported $397M of MacroGenics stock for Q1 2014, up 38% quarter-over-quarter.
- 26 funds opened new MacroGenics positions in Q1 2014 and 3 closed out, a net change of +23 holders.
- The largest MacroGenics buyer in Q1 2014 was Caisse de Depot et Placement du Quebec (CDPQ), an estimated $39.3M added.
- The largest MacroGenics seller in Q1 2014 was TPG Group Holdings (SBS) Advisors, an estimated $11.9M sold.
Based on aggregated 13F filings for Q1 2014.